Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Nanda, Ming-Hui Chen, M. Braccioforte, B. Moran, A. D'Amico (2009)
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction.JAMA, 302 8
Tao Sheng, Chengxin Li, Xiao-li Zhang, Sumin Chi, N. He, Kai Chen, F. McCormick, Z. Gatalica, Jingwu Xie (2004)
Activation of the hedgehog pathway in advanced prostate cancerMolecular Cancer, 3
A. Collins, N. Maitland (2006)
Prostate cancer stem cells.European journal of cancer, 42 9
Matthew Smith, Hang Lee, M. Fallon, D. Nathan (2008)
Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer.Urology, 71 2
(2002)
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.Circulation, 106
P. Walsh (2005)
Hedgehog signalling in prostate regeneration, neoplasia and metastasis.The Journal of urology, 173 4
G. Merrick, W. Butler, K. Wallner, R. Galbreath, Z. Allen, E. Adamovich (2006)
Androgen-deprivation therapy does not impact cause-specific or overall survival after permanent prostate brachytherapy.International journal of radiation oncology, biology, physics, 65 3
Sowers JR, Epstein M, Frohlich ED (2001)
Diabetes, hypertension, and cardiovascular disease: an update.Hypertension, 37
Mengqian Chen, M. Tanner, A. Levine, E. Levina, Patrice Ohouo, R. Buttyan (2009)
Androgenic regulation of hedgehog signaling pathway components in prostate cancer cellsCell Cycle, 8
L. Potters, T. Torre, R. Ashley, S. Leibel (2000)
Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 18 6
D. Beyer, T. McKeough, T. Thomas (2005)
Impact of short course hormonal therapy on overall and cancer specific survival after permanent prostate brachytherapy.International journal of radiation oncology, biology, physics, 61 5
Smith MR, Lee H, Nathan DM (2006)
Insulin sensitivity during combined androgen blockade for prostate cancer.J Clin Endocrinol Metab, 91
To the Editor: Dr Nanda and colleagues1 reported that hormonal therapy (HT) for prostate cancer was not associated with increased mortality in men with a single coronary artery disease (CAD) risk factor. However, their analysis may have underestimated the risk to patients with diabetes. Diabetes, unlike hypertension and hypercholesterolemia, is classified as a CAD risk equivalent, meaning that patients with diabetes have a risk comparable with nondiabetic patients with established CAD.2 Moreover, androgen suppression is associated with insulin resistance,3 possibly increasing the risk of both cardiac and noncardiac complications of diabetes. Because of this, patients with diabetes should be analyzed as a separate group, lest evidence of harm be diluted or obscured by benefit to lower-risk patients. In addition, diabetes and hypertension frequently coexist,4 so the risk calculated for patients with normotensive diabetes should not be considered representative of patients with diabetes in general. Back to top Article Information Financial Disclosures: None reported. References 1. Nanda A, Chen MH, Braccioforte MH, Moran BJ, D’Amico AV. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease–induced congestive heart failure or myocardial infarction. JAMA. 2009;302(8):866-87319706860PubMedGoogle ScholarCrossref 2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-342112485966PubMedGoogle Scholar 3. Smith MR, Lee H, Nathan DM. Insulin sensitivity during combined androgen blockade for prostate cancer. J Clin Endocrinol Metab. 2006;91(4):1305-130816434464PubMedGoogle ScholarCrossref 4. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37(4):1053-105911304502PubMedGoogle ScholarCrossref
JAMA – American Medical Association
Published: Jan 6, 2010
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.